1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > World Generic Markets 16 MARCH 2015

World Generic Markets 16 MARCH 2015

  • March 2015
  • -
  • Espicom Business Intelligence
  • -
  • 24 pages

Industry Trend Analysis - Zarxio's Approval Will See Focus Shift To Battle For Market Acceptance
Industry Trend Analysis - WTO Unlikely To Agree To Open-Ended TRIPS Implementation Deadline
Industry Brief - Actavis Initiates Budesonide Patent Challenge
Industry Trend Analysis - Compulsory Licensing Debate Highlights Weakness In International Patent Provisions
Industry Brief - Glenmark Gains New Oral Contraceptive Approval
Industry Brief - Lupin Gains US Bimatoprost Approval
Industry Brief - Jubilant Gains New US Product Approvals
Industry Brief - ANI Acquires Flecainide From Teva
Industry Brief - Cosmo And Santarus File Budesonide Patent Lawsuit Against Alvogen
Industry Brief - Actavis Loses Risedronate Patent Challenge
Industry Trend Analysis - New Acquisitions And New Corporate Identity To Reshape Impax
Industry Brief - Actavis Launches Clobetasol Cream In US
Industry Brief - Mylan Launches Disulfiram In US
Industry Brief - ANI Launches Etodolac In US
Industry Brief - Mylan Launches Fentanyl Intermediate Dosage Strengths
Industry Brief - Mylan Launches Buprenorphine In US
Industry Trend Analysis - G&W Well Placed To Acquire Teva Facility
Industry Brief - Celltrion Launches Remsima In Europe
Industry Brief - Actavis See Success In German Pemetrexed Patent Challenge
Industry Brief - Mylan Completes Abbott Acquisition
Industry Brief - Consilient Launches Pramipexole In UK
Industry Brief - Natco Enters Licensing Agreement With Gilead
Industry Trend Analysis - GSK Asset Divestment Highlights Aspen's Success

Table Of Contents

World Generic Markets 16 MARCH 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests,  Opport

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests, Opport

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-company survey from VPGMarketResearch.com contains 1,650 pages and 890 tables. The report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein ...

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...


Download Unlimited Documents from Trusted Public Sources

Anti-Infective Market in Tanzania

  • December 2016
    9 pages
  • Anti-Infective  

  • Tanzania  

    Africa  

View report >

Opioid Market in Iran

  • December 2016
    8 pages
  • Opioid  

  • Iran  

View report >

Therapy and Hormone Market in South Korea

  • December 2016
    4 pages
  • Therapy  

    Hormone  

    Cancer  

  • South Korea  

View report >

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.